Get started
Author

Míriam Fernández Delgado

Observed names: M Fernandez Delgado, M Fernández Delgado, M. Fernandez Delgado, Miriam Fernandez Delgado, Miriam Fernández Delgado
Observed institution: Ferrer Grupo (Spain)
ORCID: 0009-0002-4545-5300
Observed ORCID: 0009-0002-4545-5300
OpenAlex ID: A5069226692
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in Europe
2024 · David Montani, José M. Cifrián, et al. · ERJ Open Research · 13
PDF
The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
2024 · Lucilla Piccari, Gabor Kovacs, et al. · Pulmonary Circulation · 12
Incidence and prevalence of pulmonary hypertension in chronic lung disease: insights from a retrospective cohort study using a UK nationwide health database
2026 · David G Kiely, S John Wort, et al. · BMJ Open · 4
PDF
S81 Epidemiology, prognosis, and healthcare resource use of patients with pulmonary hypertension associated with lung disease and/or hypoxia in the UK
2025 · D Kiely, SJ Wort, et al. · Thorax
Resource use and economic burden of patients with ILD-PH in France, SNDS study
2025 · Diego Funes, Vincent Cottin, et al. · European Respiratory Journal
Épidémiologie de l’HTP associée aux maladies respiratoires et aux pneumopathies interstitielles diffuses en France : une étude en vie réelle
2025 · C. Bureau, O. Sitbon, et al. · Revue des Maladies Respiratoires Actualités
Patients souffrant de maladies pulmonaires compliquées d’une HTP en France : un lourd fardeau clinique et économique
2025 · C. Bureau, V. Cottin, et al. · Revue des Maladies Respiratoires Actualités
EPH38 Epidemiology, Prognosis, and Healthcare Resource Use of Patients With Pulmonary Hypertension Associated With Lung Disease and/or Hypoxia in the UK
2024 · D Kiely, SJ Wort, et al. · Value in Health
PDF
EE285 Conceptualization and Validation of a De Novo Cost-Effectiveness Analysis for Pulmonary Hypertension Associated With Interstitial Lung Disease
2024 · M Hopmans Galofré, M Fernandez Delgado, et al. · Value in Health
PDF
A real-word evidence study of PH-LD, PH-ILD and PAH in France, Germany, and the UK
2023 · John Wort, Juergen Behr, et al. · European Respiratory Journal
Clinical and economic burden of patients with PH-LD and PH-ILD in France
2023 · Vincent Cottin, Olivier Sitbon, et al. · European Respiratory Journal
Epidemiology of PH-LD and PH-ILD in France: a real-world evidence study
2023 · Olivier Sitbon, Vincent Cottin, et al. · European Respiratory Journal
EE46 High Doses of Treprostinil Could Entail Lower Hospitalization Costs in Patients With Pulmonary Arterial Hypertension in Nine European Countries
2022 · F Montpart Viñas, E Pomares, et al. · Value in Health
Abstract 10160: Population Eligible for PCSK9i in Spain: A Real-World Analysis
2021 · Juan Cosin Sales, Eduard Sidelnikov, et al. · Circulation
Works count: 14
Citation count: 29
H-index: 3
I10-index: 2
Year
Topic
Type